Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ACE1702 |
| Synonyms | |
| Therapy Description |
ACE1702 are natural killer (NK) cells conjugated to the ERBB2 (HER2)-targeted antibody Herceptin (trastuzumab), which potentially induce a cytotoxic response against ERBB2 (HER2)-expressing tumor cells and inhibit tumor growth (PMID: 34072864). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ACE1702 | ACE-oNK-HER2 | ACE1702 are natural killer (NK) cells conjugated to the ERBB2 (HER2)-targeted antibody Herceptin (trastuzumab), which potentially induce a cytotoxic response against ERBB2 (HER2)-expressing tumor cells and inhibit tumor growth (PMID: 34072864). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|